z-logo
Premium
13 C‐ and 14 C‐labelling of N ‐[1‐(4‐chlorophenyl)‐1H‐pyrrol‐2‐yl‐methyleneamino] guanidinium acetate
Author(s) -
Almeida Maria,
Johannesson Petra,
Boman Arne,
Lundstedt Torbjörn
Publication year - 2005
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.957
Subject(s) - chemistry , pyrrole , amide , acylation , medicinal chemistry , labelling , stereochemistry , organic chemistry , catalysis , biochemistry
N ‐[1‐(4‐chlorophenyl)‐1H‐pyrrol‐2‐yl‐ 13 C 4 ‐methyleneamino]guanidinium acetate has been synthesized by a four‐step procedure. This involved reduction of the Weinreb amide N , N′ ‐dimethyl‐ N , N′ ‐dimethyloxybutane‐1,4‐diamide‐1,2,3,4‐ 13 C 4 by Dibal‐H to give the corresponding unstable dialdehyde which is reacted in situ with 4‐chloroaniline to form 1‐(4‐chlorophenyl)‐1H‐pyrrole‐ 13 C 4 . This pyrrole analogue underwent a Vilsmeyer acylation with POCl 3 /DMF followed by final reaction with aminoguanidine bicarbonate to produce the desired labelled compound with 99% atom 13 C. By using DMF [ α ‐ 14 C] a radio‐labelled analogue was synthesized with a specific activity of 60 mCi/mmol. Copyright © 2005 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom